Suppr超能文献

成年男性中睾酮对生长激素轴的激活:芳香化作用的证据

Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization.

作者信息

Weissberger A J, Ho K K

机构信息

Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, NSW, Australia.

出版信息

J Clin Endocrinol Metab. 1993 Jun;76(6):1407-12. doi: 10.1210/jcem.76.6.8501143.

Abstract

To determine whether testosterone modulates the somatotropic axis in adult males, we compared 24-h GH secretion (from 20-min sampling, using Cluster analysis) and insulin-like growth factor-I (IGF-I) levels of five hypogonadal men (aged 20-32 yr) with those of six normal men (aged 21-27 yr), and examined the effects of testosterone replacement (testosterone enanthate 250 mg im monthly). To elucidate whether the action of testosterone on the somatotropic axis is direct, or requires the aromatization of testosterone to estradiol, we also examined the effects of the nonsteroidal antiestrogen, tamoxifen (20 mg/day for 3 weeks), on 24-h GH secretion and IGF-I levels in the normal men and in four of the hypogonadal men during concurrent testosterone treatment. Compared to the normal men, the hypogonadal men had significantly reduced mean GH pulse amplitude (3.1 +/- 0.6 vs. 8.4 +/- 1.7 micrograms/L, P < 0.05), but not pulse frequency. Testosterone treatment resulted in a significant increase in 24-h mean serum GH (0.7 +/- 0.2 to 1.4 +/- 0.2 micrograms/L, P < 0.05), mean GH pulse amplitude (3.1 +/- 0.6 to 5.2 +/- 0.8 micrograms/L, P < 0.01) and serum IGF-I (0.9 +/- 0.1 to 1.1 +/- 0.1 U/mL, P < 0.05). In the normal men, tamoxifen significantly reduced 24-h mean serum GH (1.1 +/- 0.3 to 0.5 +/- 0.1 micrograms/L, P < 0.05), mean GH pulse amplitude (8.4 +/- 1.7 to 4.7 +/- 0.4 micrograms/L, P < 0.05), and serum IGF-I (1.0 +/- 0.1 to 0.7 +/- 0.1 U/mL, P < 0.001). In the hypogonadal men on testosterone replacement, tamoxifen lowered 24-h mean serum GH (1.3 +/- 0.2 to 0.6 +/- 0.2 micrograms/L, P < 0.01), mean GH pulse amplitude (5.5 +/- 1.0 to 2.4 +/- 0.8 micrograms/L, P < 0.01), and serum IGF-I (1.2 +/- 0.1 to 0.8 +/- 0.1 U/mL, P < 0.05). We conclude that testosterone plays an important role in the modulation of the male somatotropic axis in adulthood, as appears to be the case in puberty, and that this effect is partly dependent on the aromatization of testosterone to estradiol.

摘要

为确定睾酮是否调节成年男性的生长激素轴,我们比较了5名性腺功能减退男性(年龄20 - 32岁)与6名正常男性(年龄21 - 27岁)的24小时生长激素分泌情况(采用聚类分析,每20分钟采样一次)及胰岛素样生长因子-I(IGF-I)水平,并研究了睾酮替代治疗(每月肌肉注射250 mg庚酸睾酮)的效果。为阐明睾酮对生长激素轴的作用是直接的,还是需要睾酮芳香化转化为雌二醇,我们还研究了非甾体类抗雌激素他莫昔芬(20 mg/天,共3周)对正常男性以及4名接受睾酮治疗的性腺功能减退男性的24小时生长激素分泌和IGF-I水平的影响。与正常男性相比,性腺功能减退男性的平均生长激素脉冲幅度显著降低(3.1±0.6 vs. 8.4±1.7μg/L,P < 0.05),但脉冲频率无差异。睾酮治疗导致24小时平均血清生长激素显著增加(0.7±0.2至1.4±0.2μg/L,P < 0.05)、平均生长激素脉冲幅度增加(3.1±0.6至5.2±0.8μg/L,P < 0.01)以及血清IGF-I增加(0.9±0.1至1.1±0.1 U/mL,P < 0.05)。在正常男性中,他莫昔芬显著降低了24小时平均血清生长激素(1.1±0.3至0.5±0.1μg/L,P < 0.05)、平均生长激素脉冲幅度(8.4±1.7至4.7±0.4μg/L,P < 0.05)以及血清IGF-I(1.0±0.1至0.7±0.1 U/mL,P < 0.001)。在接受睾酮替代治疗的性腺功能减退男性中,他莫昔芬降低了24小时平均血清生长激素(1.3±0.2至0.6±0.2μg/L,P < 0.01)、平均生长激素脉冲幅度(5.5±1.0至2.4±0.8μg/L,P < 0.01)以及血清IGF-I(1.2±0.1至0.8±0.1 U/mL,P < 0.05)。我们得出结论,睾酮在成年男性生长激素轴的调节中起重要作用,这与青春期的情况类似,且这种作用部分依赖于睾酮芳香化转化为雌二醇。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验